Stereotactic biopsy for intracranial lesions: Clinical-pathological compatibility in 60 patients

Arquivos de Neuro-Psiquiatria

Volumn 67, Issue 4, 2009, Pages 1062-1065

  Da Silva, Eduardo Urbano ^a   De Vasconcellos, Lucas Perez ^a   Lara Jr , Nilton Alves ^a   Veiga, José Carlos Esteves ^a   Lancellotti, Carmen Lúcia Penteado ^b   Shiozawa, Pedro ^b  

^a Charity Hospital Santa Casa de Misericórdia   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Accuracy; Morbidity; Pathology; Stereotactic biopsy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOSIS; BRAIN HEMORRHAGE; BRAIN INFECTION; BRAIN LYMPHOMA; BRAIN METASTASIS; BRAIN TISSUE; BRAIN VASCULITIS; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUROIMAGING; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; SCHOOL CHILD; STEREOTACTIC BIOPSY;

EID: 76149092898     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2009000600019     Document Type: Article

References (27)

1. Friedman WA, Sceats DJ Jr, Nestok BR, Ballinger WE Jr. The incidence of unexpected pathological findings in an image-guided biopsy series: a review of 100 consecutive cases. Neurosurgery 1989;25:180-185.
2. Lobato RD, Rivas JJ, Cabello A, Roger R. Stereotactic biopsy of brain lesions visualized with computed tomography. Appl Neurophysiol 1982; 45:426-430.
3. Wild AM, Xuereb JH, Marks PV, Gleave JR. Computerized tomographic stereotaxy in the management of 200 consecutive intracranial mass lesions. Analysis of indications, benefits and outcome. Br J Neurosurg 1990;4:407-415.
4. McGirt MJ, Woodwoth GF, Coon AL, Frazier JM. Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 2005;102:897-901.
5. Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998;82:1749-1755.
6. Greene GM, Hitchon PW, Schelper RL, Yuh W, Dyste GN. Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg. 1989;71: 494-497.
7. Apuzzo ML, Chandrasoma PT, Cohen D, Zee CS, Zelman V. Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses. Neurosurgery 1987;20:930-937.
8. Bernays RL, Kollias SS, Khan N, Brandner S, Meier S, Yonekawa Y. Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J Neurosurg 2002;97:354-362.
9. Blaauw G, Braakman R. Pitfalls in diagnostic stereotactic brain surgery. Acta Neurochir 1988;42(Suppl):S161-S165.
10. Bouvier G, Couillard P, Leger SL, Lesage J, Rotent F, Beigne RA. Stereotactic biopsy of cerebral space-occupying lesions. Appl Neurophysiol 1983;46:227-230.
11. Dorward NL, Paleologos TS, Alberti O, Thomas DG. The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg 2002;16:110-118.
12. Field M, Witham TF, Flickinger JC, Kondziolka D, Lunsford LD. Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 2001;94:545-551.
13. Gralla J, Nimsky C, Buchfelder M, Fahlbusch R, Ganslandt O. Frameless stereotactic brain biopsy procedures using the Stealth Station: indications, accuracy, and results. Zentralbl Neurochir 2003;64:166-170.
14. Yu X, Liu Z, Tian Z, et al. Stereotactic biopsy for intracranial space-occupying lesions: clinical analysis of 550 cases. Stereotact Funct Neurosurg 2000;75:103-108.
15. Clarke RH. Investigations of the central nervous system: methods and instruments. Jonhs Hopkins Hospital Report, Special Volume,1920:1-162.
16. Horsley V, Clark RH. The structure and function of cerebellum examined by new method. Brain 1906;31:45-124.
17. Spiegel EA, Wycis HJ, Marks M, Lee A. Stereotactic apparatus for operations. Science 1947;106:439-450.
18. Kelly PJ. Tumor stereotaxis, Philadelphia: WB Saunders, 1991:1-220.
19. Apuzzo MLJ, Sabshin JK. Computed tomographic guidance stereotaxis in management of intracranial mass lesions. Neurosurgery 1983;12:277-285.
20. Schlitt MJ, Morawetz, Bonnin JM, Zeiger HE, Whitlety RJ. Brain biopsy for encephalitis. Clin Neurosurg 1986;33:591-602.
21. Woodworth GF, McGirt MJ,Samdani A. Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg 2006;104: 233-237.
22. McGirt MJ, Woodworth GF, Coon AL. Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 2005;102:897-901.
23. Ostertag CB, Mennel HD, Kiessling M. Stereotactic biopsy of brain tumors. Surg Neurol 1980;14:275-283.
24. Hisatugo MK, Stávale JN, Bidó JO, Ferraz FP. Image guided stereotactic approach of central nervous system lesions: accuracy, morbidity and mortality. Arq Neuropsiquiatr 1999;57:615-620.
25. Berkeley BB, Adams JH, Doyle D, Graham DI, Harper CG. The smear technique in the diagnosis of neurosurgical biopsies. N Z Med J 1978;87: 12-15.
26. Ciricillo SF, Rosenblum ML. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 1990;73:720-724.
27. Kulkarni AV, Guha A, Lozano A, Berstein M. Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 1998;89:31-35.